0001358403-19-000112.txt : 20190823
0001358403-19-000112.hdr.sgml : 20190823
20190823160417
ACCESSION NUMBER: 0001358403-19-000112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190821
FILED AS OF DATE: 20190823
DATE AS OF CHANGE: 20190823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Naeve Gregory S.
CENTRAL INDEX KEY: 0001714833
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 191049166
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_156659064157849.xml
FORM 4
X0306
4
2019-08-21
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001714833
Naeve Gregory S.
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Chief Business Officer
Common Stock
2019-08-21
4
F
0
1597
0.9477
D
13746
D
Represents the number of shares withheld by and surrendered to the Issuer on August 21, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on August 21, 2017 for 15,000 shares, of which 3,750 vested on August 21, 2019. The RSUs vest in four equal annual installments beginning August 21, 2018.
Includes 902 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan on June 10, 2019.
/s/ Rosemary Y. Williams, Attorney-in-Fact
2019-08-23